Topic: statistical analysis
Calls are growing for a new approach to p-values.
The biotech is adding 510 patients to the phase 3 aducanumab trials after seeing more “variability” than expected in a sample size re-estimation.
INC extended its contract with Medidata for a few more years and started using two more products of the tech firm. Executives from both companies told us more.